Literature DB >> 28107741

Building-related symptoms are linked to the in vitro toxicity of indoor dust and airborne microbial propagules in schools: A cross-sectional study.

J T Salin1, M Salkinoja-Salonen2, P J Salin3, K Nelo4, T Holma5, P Ohtonen6, H Syrjälä7.   

Abstract

INTRODUCTION: Indoor microbial toxicity is suspected to cause some building-related symptoms, but supporting epidemiological data are lacking.
OBJECTIVE: We examined whether the in vitro toxicity of indoor samples from school buildings was associated with work-related health symptoms (building-related symptoms, BRS).
METHODS: Administrators of the Helsinki City Real Estate Department selected 15 schools for the study, and a questionnaire on symptoms connected to work was sent to the teachers in the selected schools for voluntary completion. The cellular toxicity of classroom samples was determined by testing substances extracted from wiped indoor dust and by testing microbial biomass that was cultured on fallout plates. Boar sperm cells were used as indicator cells, and motility loss was the indicator for toxic effects. The effects were expressed as the half maximal effective concentration (EC50) at which >50% of the exposed boar sperm cells were immobile compared to vehicle control.
RESULTS: Completed symptom questionnaires were received from 232 teachers [median age, 43 years; 190 (82.3%) women] with a median time of 6 years working at their school. Samples from their classrooms were available and were assessed for cellular toxicity. The Poisson regression model showed that the impact of extracts of surface-wiped school classroom dust on teacher work-related BRS was 2.8-fold (95% CI: 1.6-4.9) higher in classrooms with a toxic threshold EC50 of 6µgml-1 versus classrooms with insignificant EC50 values (EC50 >50µgml-1); P<0.001. The number of symptoms that were alleviated during vacation was higher in school classrooms with high sperm toxicity compared to less toxic sites; the RR was 1.9 (95% CI: 1.1-3.3, P=0.03) for wiped dust extracts.
CONCLUSIONS: Teachers working in classrooms where the samples showed high sperm toxicity had more BRS. The boar sperm cell motility inhibition assay appears promising as a tool for demonstrating the presence of indoor substances associated with BRS.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Airborne toxicity, sperm motility; Building-related symptoms; Indoor dust; Indoor toxicity

Mesh:

Substances:

Year:  2017        PMID: 28107741     DOI: 10.1016/j.envres.2017.01.015

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  6 in total

1.  Association of toxic indoor air with multi-organ symptoms in pupils attending a moisture-damaged school in Finland.

Authors:  Saija M Hyvonen; Jouni J Lohi; Leena A Rasanen; Tuula Heinonen; Marika Mannerstrom; Kirsi Vaali; Tamara Tuuminen
Journal:  Am J Clin Exp Immunol       Date:  2020-12-15

2.  The Response of Phagocytes to Indoor Air Toxicity.

Authors:  Liisa K Vilén; Janne Atosuo; Esa-Matti Lilius
Journal:  Front Immunol       Date:  2017-07-28       Impact factor: 7.561

3.  Response: Commentary: Severe Sequelae to Mold-Related Illness as Demonstrated in Two Finnish Cohorts.

Authors:  Tamara Tuuminen; Kyösti Rinne
Journal:  Front Immunol       Date:  2018-06-11       Impact factor: 7.561

4.  Asthma Case Cluster during Renovation of a Water-Damaged and Toxic Building.

Authors:  Saija Hyvönen; Hannu Syrjala
Journal:  Microorganisms       Date:  2019-12-03

5.  Antifungal Activity of Polyoxometalate-Ionic Liquids on Historical Brick.

Authors:  Katarzyna Rajkowska; Anna Koziróg; Anna Otlewska; Małgorzata Piotrowska; Elena Atrián-Blasco; Isabel Franco-Castillo; Scott G Mitchell
Journal:  Molecules       Date:  2020-12-01       Impact factor: 4.411

6.  Toxic Indoor Air Is a Potential Risk of Causing Immuno Suppression and Morbidity-A Pilot Study.

Authors:  Kirsi Vaali; Marja Tuomela; Marika Mannerström; Tuula Heinonen; Tamara Tuuminen
Journal:  J Fungi (Basel)       Date:  2022-01-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.